The role of continuous glucose sensors in diabetes care

Endocrinology and Metabolism Clinics of North America

Volumn 33, Issue 1, 2004, Pages 163-173

  Garg, Satish K ^a,b   Hoff, Halsley K ^b   Chase, H Peter ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SENSOR; UNITED STATES;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 1842422039     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2004.01.001     Document Type: Review

References (25)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977.
2. UK Prospective Diabetes Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837.
3. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective six year study. Diabetes Res Clin Pract. 28:1995;103.
4. Garg S.K., Schwartz S., Edelman S.V. Improved glucose excursions using an implantable real-time continuous implanted glucose sensor in adults with type 1 diabetes. N Engl J Med. 27:2004;. in press.
5. Centers for Disease Control and Prevention. National Diabetes Fact Sheet. Available at: http://www.cdc.gov/diabetes/pubs/estimates.htm. Accessed January 23, 2004.
6. Chase H.P., Kim L.M., Owen S.L., et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics. 107:2001;222.
7. Kerr D. Continuous blood glucose monitoring: detection and prevention of hypoglycaemia. Int J Clin Pract Suppl. 123:2001;43.
8. Ludvigsson J., Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 111:2003;933.
9. Gross T.M., Bode B.W., Einhorn D. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2:2000;49.
10. Salardi S., Zucchini S., Santoni R., et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care. 25:2002;1840.
11. Guerci B., Floriot M., Bohme P., et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care. 26:2003;582.
12. Amin R., Ross K., Acerini C.L., et al. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care. 26:2003;662.
13. Caplin N.J., O'Leary P., Bulsara M., et al. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabetes Medicine. 20:2003;238.
14. Schaffini R., Ciampalini P., Fierabracci A., et al. The continuous glucose monitoring system (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev. 18:2002;324.
15. Tierney M.J., Tamada J.A., Potts R.O., et al. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron. 16:2001;621.
16. Garg S.K., Potts R.O., Ackerman N.R., et al. Correlation of fingerstick blood glucose measurement with GlucoWatch Biographer glucose results in young patients with type 1 diabetes. Diabetes Care. 22:1999;1708.
17. Tierney M.J., Garg S.K., Ackerman N.R. Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch Biographer. Diabetes Technol Ther. 2:2000;199.
18. Tamada J.A., Garg S.K., Jovanovic L., et al. Noninvasive glucose monitoring. JAMA. 282:1999;1839.
19. Eastman R.C. Glucose sensing using the GlucoWatch Biographer emerging data on clinical utility. Business briefing: European pharmacotherapy. 2003;Business Briefing Ltd, London.
20. Garg S.K., Chase H.P., Fermi S.J., et al. Evaluation of GlucoWatch Biographer performance during continuous daily wear for six weeks. Presented at the American Diabetes Association 60th Scientific Session. San Antonio, June 9-13, 2000. Diabetes. 49:(Suppl 1):2000;A127.
21. Chase H.P., Roberts M.D., Wightman C., et al. Use of the GlucoWatch Biographer in children with type 1 diabetes. Pediatrics. 111:2003;790.
22. nd Scientific Sessions. San Francisco, June 14-18, 2002. Diabetes. 51:(Suppl 2):2002;A125.
23. nd Scientific Sessions. San Francisco, June 14-18, 2002. Diabetes. 51:(Suppl 2):2002;A122.
24. Larin K., Eledrisi M., Motamedi M., et al. Noninvasive blood glucose monitoring with optical coherence tomography. Diabetes Care. 25:2002;2263.
25. McShane M.J. Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technol Ther. 4:2002;533.